| Stage | NVST | % of rev | CVSA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $731M | 100.00% | $512M | 100.00% | NVST ×1.43 |
| Gross profit | $407M | 55.72% | $291M | 56.84% | CVSA +1.1pp |
| Operating income | $80M | 10.99% | $98M | 19.16% | CVSA +8.2pp |
| Pre-tax income | $74M | 10.18% | $89M | 17.50% | CVSA +7.3pp |
| Net income | $54M | 7.35% | $67M | 13.18% | CVSA +5.8pp |
| Stage | NVST | CVSA | Gap · A − B |
|---|---|---|---|
| Revenue | $731M100.00% | $512M100.00% | NVST ×1.43 |
| Gross profit | 55.72%$407M | 56.84%$291M | CVSA +1.1pp |
| Operating income | 10.99%$80M | 19.16%$98M | CVSA +8.2pp |
| Pre-tax income | 10.18%$74M | 17.50%$89M | CVSA +7.3pp |
| Net income |
| 7.35%$54M |
| 13.18%$67M |
| CVSA +5.8pp |
No shared counterparties.